ID: ALA4217965

Max Phase: Preclinical

Molecular Formula: C20H26O2

Molecular Weight: 298.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CCCCCCCc2ccccc2O)cc1

Standard InChI:  InChI=1S/C20H26O2/c1-22-19-15-13-17(14-16-19)9-5-3-2-4-6-10-18-11-7-8-12-20(18)21/h7-8,11-16,21H,2-6,9-10H2,1H3

Standard InChI Key:  OGLWBPXGSOGEAQ-UHFFFAOYSA-N

Associated Targets(non-human)

Prostaglandin E synthase 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 298.43Molecular Weight (Monoisotopic): 298.1933AlogP: 5.14#Rotatable Bonds: 9
Polar Surface Area: 29.46Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.30CX Basic pKa: CX LogP: 6.27CX LogD: 6.27
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.65Np Likeness Score: 0.19

References

1. McLane RD, Le Cozannet-Laidin L, Boyle MS, Lanzillotta L, Taylor ZL, Anthony SR, Tranter M, Onorato AJ..  (2018)  Synthesis and PGE2 inhibitory activity of novel diarylheptanoids.,  28  (3): [PMID:29290543] [10.1016/j.bmcl.2017.12.046]

Source